The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
复制标题
DOI:
10.1016/j.bbrc.2022.06.086
复制
发表时间:
2022-07
影响因子:
3.1
通讯作者:
Xiating Mao;Danning Wu;Na Xu;Jingjing Wang;Jinhua Zeng;Zhiqiang Jiang;Yingfang Liu;Huanhuan Liang
中科院分区:
文献类型:
--
作者:
Xiating Mao;Danning Wu;Na Xu;Jingjing Wang;Jinhua Zeng;Zhiqiang Jiang;Yingfang Liu;Huanhuan Liang
Acute liver injury caused by overdose usage of acetaminophen (APAP) is an intractable clinical problem. Necrotic hepatocytes release large amounts of intracellular components including damage-associated molecular patterns (DAMPs) which contribute to liver failure and may serve as therapeutic targets. However, the pathogenic mechanisms of DAMPs in APAP-induced liver injury (AILI) are remain largely uncovered. Here, we found that a recently identified DAMP, interferon-induced protein 35 (IFP35), is involved in the early phase of AILI. Our data demonstrated that although the expression level of IFP35 is not significantly increased in either patients or mice with AILI, it is released from necrotic hepatocytes. Within 24 h post APAP injection, mice lackingIfp35are resistant to APAP-induced toxicity, and induce less inflammatory response than that of wild-type mice, including reduced AST/ALT level, pro-inflammatory cytokines production and neutrophils infiltration. More importantly, antibody of IFP35 reduces the expression level of inflammatory factors and chemokines. This study brings new knowledge into the pathogenic mechanism of AILI.